Latest News Archive

Please select Category, Year, and then Month to display items

UFS and ARC establish research chairs to address climate change

12 July 2024 | Story André Damons | Photo André Damons

Research Chairs 2024 — Prof Paul Oberholster, Dean: NAS; Dr Glen Taylor, Senior Director for the Directorate Research Development (DRD); Prof Vasu Reddy, Deputy Vice-Chancellor, Research and Internationalisation; and Prof Johan van Niekerk, Vice-Dean for Agriculture in the Faculty of Natural and Agricultural Sciences (NAS); are excited for the new ARC-DALLRD-UFS research chairs.

In a concerted effort to address the challenges and impact of climate change in Southern Africa, the University of the Free State (UFS) together with the Agricultural Research Council (ARC) and the Department of Agriculture, Land Reform and Rural Development (DALRRD) established four new research chairs within the Faculty of Natural and Agricultural Sciences (NAS).

The ARC-DALLRD-UFS research chairs, namely Climate Change and Agriculture, Innovative Agro-processing for Climate-smart Food System, Agriculture Risk Financing and Sustainable Livestock Production, falls under the umbrella of climate change and are part of the established centre of excellence of the ARC and DALRRD on Climate Smart Agriculture.

They will form part of two centres of excellence that the university is also in the process of establishing. The framework for these Agriculture Research Centres of Excellence involves several key components aimed at fostering innovation, collaboration, and impactful research in agriculture. In this case it is Climate Smart Agriculture, enabling them to play a pivotal role in advancing agriculture, enhancing productivity, sustainability, and resilience in the face of global challenges related to climate change.

Prof Johan van Niekerk, Vice-Dean for Agriculture for NAS, and Prof Sonja Venter, from the ARC, are the coordinators for the ARC-UFS-consortium. Joel Mamabolo from the DALRRD is the department’s representative and DALRRD manager in the consortium.

The purpose of the research chairs, he explains, is to conduct high-level research with an aspect of community impact as envisaged in the university’s vision 130. This is the UFS and NAS’s first steps towards creating industry chairs with negotiations between the UFS and the ARC-DALRRD currently taking place for further expansion of the chairs.

Improve research and food security

“The UFS has a long-standing relationship with the ARC and the parties came together to work together to improve research and food security in South Africa and Sub-Saharan Africa. The best way to do this, was by creating research chairs. The ARC saw the university’s expertise in agriculture which also contributed to the ARC establishing the chairs. Our expertise is of such a nature that it does not only influence the sector, but also makes a lasting difference,” says Prof Van Niekerk.

According to him, the ARC and the UFS will collectively manage the research chairs by appointing co-chair principal scientists for each of the chairs in order for the chairs to work together and share resources and expertise. The ARC-DALLRD-UFS research chairs will also work closely together within multidisciplinary research teams and complement each other and in doing so, create a value chain within the agriculture sector.

It will integrate various disciplines including agronomy, genetics, soil science, ecology, pathology economics, socioeconomics horticulture, animal sciences, food sciences and engineering to mention a few. This multidisciplinary approach will foster comprehensive research solutions and innovation at the intersection of different fields and will aim to contribute to sustainable food systems for the future.

The first two chairs; Climate Change and Agriculture, headed by Prof Linus Franke, Head of the UFS Department of Soil, Crop, and Climate Sciences, and the Innovative Agro-processing for Climate-smart Food System, which will be under Dr Alba du Toit, Senior Lecturer in the Department of Sustainable Food Systems and Development, officially started on 1 July 2024, while the remaining two chairs will begin operating in December. The ARC will soon confirm the co-leaders of the various chairs.

The Agriculture Risk Financing research chair will be shared between the Department of Agricultural Economics, within NAS, and the UFS Business School. The Sustainable Livestock Production chair will fall within Prof Frikkie Neser’s Department of Animal Science. To add more credibility, experience and expertise to the ARC-DALLRD-UFS research chairs, Prof Maryke Labuschagne, who is leading the NRF SARChI Chair in Diseases and Quality of Field Crops, has been appointed as mentor.

Prof Vasu Reddy, Deputy Vice-Chancellor, Research and Internationalisation, says: “These chairs mark an exciting opportunity to deepen our understanding of climate change aligned to our expertise in agriculture. The chairs offer us the opportunity to honour and support the leaders who will contribute in powerful ways to the vibrant intellectual life of the faculty, as well as the university, the ARC and DALRRD.

“The chairs also honour the donor whose financial support makes this form of recognition possible. At the UFS we are committed to engaging in global challenges but with a deliberate local focus, energy and drive. I am especially excited that these chairs demonstrate a commitment to the UFS focus on partnerships with industry, communities, the state and other academic and research institutions both nationally and around the world.”

Grateful for the ARC relationship

Through these chairs more collaborators and partners from other universities in the country and globally will be included in the partnership with the aim to bring together internationally renowned scientific experts that will collectively focus to address global challenges and enhance the development of more scientific capacity for the country.

The university, Prof Van Niekerk continues, is grateful for the cooperation and relationship with the ARC and its President and CEO, Dr Litha Magingxa and the executive management team, as well as the DALRRD DG, Mooketsa Ramasodi and the DDG for Agricultural Production, Biosecurity and Natural Resources Management, Dipepeneneng Serage for creating an environment within which the Universities and ARC can collectively contribute towards developing solutions with the DALRRD for key agricultural challenges of the country.

He expressed his gratitude to the Directorate Research Development (DRD) under the leadership of Dr Glen Taylor, for not only their support, but for bringing the parties together and negotiating with the ARC on their behalf. In this regard he wishes to thank Dr Petronella Chaminuka from the ARC as the acting Executive Manager: Research support and coordination for her support, guidance and leadership during the process.

Prof Van Niekerk also thanked Profs Francis Petersen, UFS Vice-Chancellor and Principal, Reddy, and Paul Oberholster, Dean of the Faculty of NAS, for creating the environment and rendering immense support for this programme from the UFS.

News Archive

Stem cell research and human cloning: legal and ethical focal points

2004-07-29

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept